Paras Health Posts Strong Q2 Performance With 43% YoY EBITDA Growth
Paras Healthcare Limited 路 Press Release 路 06 Nov 2026, 1:20 am
Paras Health Posts Strong Q2 Performance With 43% YoY EBITDA Growth Paras Healthcare reported strong Q2 FY27 results, with revenue rising 22.8% YoY (8.6% QoQ) to Rs 510.9 crore. EBITDA expanded 42.5% YoY to Rs 126.6 crore, expanding margins by 350 bps YoY to 24.5%. PAT jumped 3.3x YoY to Rs 40.4 crore. H1 FY27 revenue reached Rs 981.2 crore (+25.1% YoY) with PAT of Rs 90.0 crore (8.7x YoY), supported by bed occupancy rising to 73.0% and ARPOB at Rs 48.9K. The company utilized Rs 375 crore of IPO proceeds for debt repayment.
Original exchange filing (PDF)
More announcements from Paras Healthcare Limited
- Transcript of the Earnings Conference Call held to discuss the Financial Results of the Company for the Quarter and half year ended September 30, 2026 路 13 Nov 2026
- Schedule of Investor Meet under Regulation 30 of SEBI Listing Regulations 路 12 Nov 2026
- Audio Recording of Earnings Call on Financial Results of the Company for the Quarter and Half Year ended September 30, 2026 路 07 Nov 2026
- Investor Presentation on Financial Results of the Company for the Quarter and Half Year Ended September 30, 2026 路 06 Nov 2026
- Disclosure under Regulation 30 of Listing Regulation 路 06 Nov 2026
- Paras Healthcare Limited has informed the Exchange regarding Change in Director(s) of the company. 路 06 Nov 2026
- Board Approved Unaudited Financials Results for Quarter and Half Year ended September 30, 2026 路 06 Nov 2026
- Paras Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 06 Nov 2026
